Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2016-04-08

Clinical Trial Update: TEOSYAL® PureSense Redensity [I] Injection Using MicronJet® Needle in the Treatment of Crow's Feet Wrinkles [Phase 4]

View source ↗

Summary

A Phase 4 study evaluating TEOSYAL PureSense Redensity I injectable filler with MicronJet needle for crow's feet wrinkles has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • TEOSYAL PureSense Redensity I (Hyaluronic acid dermal filler)

Snippet

Sponsor: Teoxane SA | Conditions: Crow's Feet Wrinkles | Phase 4 | Status: COMPLETED